Seizure therapy and suppression using an implantable device

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070213784A1
SERIAL NO

11374379

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A system and method for detecting neurological conditions, including periods of high ictal activity and periods of low ictal activity, uses a relatively low-power central processing unit in connection with signal processing circuitry to identify characteristics of an electrographic signal received from a patient's brain. Cerebral blood flow may also be monitored. Observed characteristics are used to drive targeted responsive therapy and suppressive responsive therapy, or the modulation of cerebral blood flow, to prevent or terminate imminent seizures and to reduce the likelihood of future seizures.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEUROPACE INC455 N BERNARDO AVENUE MOUNTAIN VIEW CA 94043

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pless, Benjamin D Atherton, CA 125 10900

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation